PI3K signaling: A key pathway in the control of sympathetic traffic and arterial pressure by leptin

Molecular Metabolism

Volumn 2, Issue 2, 2013, Pages 69-73

  Harlan, Shannon M ^a   Rahmouni, Kamal ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Autonomic nervous system; Cardiovascular function; Energy homeostasis; Leptin; PI3K

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE;

ARCUATE NUCLEUS; ARTERIAL PRESSURE; BLOOD PRESSURE REGULATION; BRAIN NERVE CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; DISEASE ASSOCIATION; ENERGY BALANCE; HORMONE RESISTANCE; HUMAN; HYPERTENSION; INTRACELLULAR SIGNALING; MOLECULAR MECHANICS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYMPATHETIC FUNCTION; SYMPATHETIC TONE;

EID: 84877653875     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2013.03.004     Document Type: Review

References (58)

1. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
2. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
3. Rahmouni K., Haynes W.G. Leptin and the cardiovascular system. Recent Progress in Hormone Research 2004, 59:225-244.
4. Harlan S.M., Rahmouni K. Neuroanatomical determinants of the sympathetic nerve responses evoked by leptin. Clinical Autonomic Research 2013, 23:1-7.
5. Chehab F.F., Lim M.E., Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genetics 1996, 12:318-320.
6. Bates S.H., Stearns W.H., Dundon T.A., Schubert M., Tso A.W., Wang Y., et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003, 421:856-859.
7. Shi Y., Yadav V.K., Suda N., Liu X.S., Guo X.E., Myers M.G., et al. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proceedings of the National Academy of Sciences of USA 2008, 105:20529-20533.
8. Gertler A. Development of leptin antagonists and their potential use in experimental biology and medicine. Trends in Endocrinology and Metabolism 2006, 17:372-378.
9. Coppari R., Bjorbaek C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nature Reviews Drug Discovery 2012, 11:692-708.
10. Rahmouni K., Correia M.L., Haynes W.G., Mark A.L. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005, 45:9-14.
11. Konner A.C., Bruning J.C. Selective insulin and leptin resistance in metabolic disorders. Cell Metabolism 2012, 16:144-152.
12. Tartaglia L.A. The leptin receptor. Journal of the Biological Chemistry 1997, 272:6093-6096.
13. Myers M.G., Cowley M.A., Munzberg H. Mechanisms of leptin action and leptin resistance. Annual Review of Physiology 2008, 70:537-556.
14. Morris D.L., Rui L.Y. Recent advances in understanding leptin signaling and leptin resistance. American Journal of Physiology-Endocrinology and Metabolism 2009, 297:E1247-E1259.
15. Gong Y., Ishida-Takahashi R., Villanueva E.C., Fingar D.C., Muenzberg H., Myers M.G. The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms. Journal of Biological Chemistry 2007, 282:31019-31027.
16. Myers M.G. Deconstructing leptin: from signals to circuits. Diabetes 2010, 59:2708-2714.
17. Bjorbaek C., Buchholz R.M., Davis S.M., Bates S.H., Pierroz D.D., Gu H., et al. Divergent roles of SHP-2 in ERK activation by leptin receptors. Journal of Biological Chemistry 2001, 276:4747-4755.
18. Zhang E.E., Chapeau E., Hagihara K., Feng G.S. Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proceedings of the National Academy of Sciences of USA 2004, 101:16064-16069.
19. Zabolotny J.M., Bence-Hanulec K.K., Stricker-Krongrad A., Haj F., Wang Y., Minokoshi Y., et al. PTP1B regulates leptin signal transduction in vivo. Developmental Cell 2002, 2:489-495.
20. Berti L., Kellerer M., Capp E. Haring HU. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: Evidence for a PI3-kinase mediated effect. Diabetologia 1997, 40:606-609.
21. Zhao A.Z., Shinohara M.M., Huang D.M., Shimizu M., Eldar-Finkelman H., Krebs E.G., et al. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. Journal of Biological Chemistry 2000, 275:11348-11354.
22. Harvey J., McKay N.G., Walker K.S., Van der K.J., Downes C.P., Ashford M.L. Essential role of phosphoinositide 3-kinase in leptin-induced K(ATP) channel activation in the rat CRI-G1 insulinoma cell line. Journal of Biological Chemistry 2000, 275:4660-4669.
23. Hill J.W., Williams K.W., Ye C., Luo J., Balthasar N., Coppari R., et al. Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. Journal of Clinical Investigation 2008, 118:1796-1805.
24. Zhao A.Z., Huan J.N., Gupta S., Pal R., Sahu A. A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nature Neuroscience 2002, 5:727-728.
25. Plum L., Rother E., Munzberg H., Wunderlich F.T., Morgan D.A., Hampel B., et al. Enhanced leptin-stimulated Pi3k activation in the CNS promotes white adipose tissue transdifferentiation. Cell Metabolism 2007, 6:431-445.
26. Kitamura T., Feng Y., Kitamura Y.I., Chua S.C., Xu A.W., Barsh G.S., et al. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nature Medicine 2006, 12:534-540.
27. Niswender K.D., Morton G.J., Stearns W.H., Rhodes C.J., Myers M.G., Schwartz M.W. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 2001, 413:794-795.
28. Rahmouni K., Haynes W.G., Morgan D.A., Mark A.L. Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 2003, 41:763-767.
29. Al Qassab H., Smith M.A., Irvine E.E., Guillermet-Guibert J., Claret M., Choudhury A.I., et al. Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons. Cell Metabolism 2009, 10:343-354.
30. Xu A.W., Kaelin C.B., Takeda K., Akira S., Schwartz M.W., Barsh G.S. PI3K integrates the action of insulin and leptin on hypothalamic neurons. Journal of Clinical Investigation 2005, 115:951-958.
31. Xu Y., Hill J.W., Fukuda M., Gautron L., Sohn J.W., Kim K.W., et al. PI3K signaling in the ventromedial hypothalamic nucleus is required for normal energy homeostasis. Cell Metabolism 2010, 12:88-95.
32. Hall J.E., da Silva A.A., do Carmo J.M., Dubinion J., Hamza S., Munusamy S., et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. Journal of Biological Chemistry 2010, 285:17271-17276.
33. Rahmouni K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Current Hypertension Reviews 2010, 6:104-109.
34. Mark A.L., Shaffer R.A., Correia M.L., Morgan D.A., Sigmund C.D., Haynes W.G. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. Journal of Hypertension 1999, 17:1949-1953.
35. Shek E.W., Brands M.W., Hall J.E. Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31:409-414.
36. Aizawa-Abe M., Ogawa Y., Masuzaki H., Ebihara K., Satoh N., Iwai H., et al. Pathophysiological role of leptin in obesity-related hypertension. Journal of Clinical Investigation 2000, 105:1243-1252.
37. Carlyle M., Jones O.B., Kuo J.J., Hall J.E. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002, 39:496-501.
38. Rahmouni K., Sigmund C.D., Haynes W.G., Mark A.L. Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 2009, 58:536-542.
39. Bates S.H., Dundon T.A., Seifert M., Carlson M., Maratos-Filer E., Myers M.G. LRb-STAT3 signaling is required for the neuroendocrine regulation of energy expenditure by leptin. Diabetes 2004, 53:3067-3073.
40. Harlan S.M., Morgan D.A., Dellsperger D.J., Myers M.G., Mark A.L., Rahmouni K. Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor. Hypertension 2011, 57:627-632.
41. Bjornholm M., Munzberg H., Leshan R.L., Villanueva E.C., Bates S.H., Louis G.W., et al. Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. Journal of Clinical Investigation 2007, 117:1354-1360.
42. Harlan S, Guo DF, Morgan DA, Fernandes-Santos C, Rahmouni K. Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects. Cell Metabolism 2013, , in press. http://dx.doi.org/10.1016/j.cmet.2013.02.017.
43. Foukas L.C., Claret M., Pearce W., Okkenhaug K., Meek S., Peskett E., et al. Critical role for the p110 alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 2006, 441:366-370.
44. Hall J.E., Brands M.W., Hildebrandt D.A., Kuo J., Fitzgerald S. Role of sympathetic nervous system and neuropeptides in obesity hypertension. Brazilian Journal of Medical and Biological Research 2000, 33:605-618.
45. Esler M., Straznicky N., Eikelis N., Masuo K., Lambert G., Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006, 48:787-796.
46. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension achievements and perspectives. Hypertension 2009, 54:690-697.
47. Vaz M., Jennings G., Turner A., Cox H., Lambert G., Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997, 96:3423-3429.
48. Kassab S., Kato T., Wilkins F.C., Chen R., Hall J.E., Granger J.P. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995, 25:893-897.
49. Lohmeier T.E., Iliescu R., Liu B., Henegar J.R., Maric-Bilkan C., Irwin E.D. Systemic and renal-specific sympathoinhibition in obesity hypertension. Hypertension 2012, 59:331-338.
50. Eikelis N., Schlaich M., Aggarwal A., Kaye D., Esler M. Interactions between leptin and the human sympathetic nervous system. Hypertension 2003, 41:1072-1079.
51. Correia M.L., Haynes W.G., Rahmouni K., Morgan D.A., Sivitz W.I., Mark A.L. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002, 51:439-442.
52. Rahmouni K., Haynes W.G., Morgan D.A., Mark A.L. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002, 39:486-490.
53. Rahmouni K., Morgan D.A., Morgan G.M., Mark A.L., Haynes W.G. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 2005, 54:2012-2018.
54. Rahmouni K., Fath M.A., Seo S., Thedens D.R., Berry C.J., Weiss R., et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. Journal of Clinical Investigation 2008, 118:1458-1467.
55. Morgan D.A., Thedens D.R., Weiss R., Rahmouni K. Mechanisms mediating renal sympathetic activation to leptin in obesity. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2008, 295:R1730-R1736.
56. Prior L.J., Eikelis N., Armitage J.A., Davern P.J., Burke S.L., Montani J.P., et al. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 2010, 55:862-896.
57. Harlan S.M., Morgan D.A., Agassandian K., Guo D.F., Cassell M.D., Sigmund C.D., et al. Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation. Circulation Research 2011, 108:808-812.
58. 1077 contributes to the control of energy balance and female reproduction. Molecular Metabolism 2012, 1:61-69.